Bulawit, Eva Mae N.

HRN: 22-80-46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2023
CEFUROXIME 1.5GM (VIAL)
05/12/2023
05/12/2023
IVT
1.5g
On Call To OR
For CS
Waiting Final Action 
05/14/2023
METRONIDAZOLE 500MG (TAB)
05/14/2023
05/21/2023
ORAL
500mg
TID
S/P LTCS; Thickly Msaf
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: